Aetion (pronounced eh-tee-ahn) is a leading healthcare technology company that delivers the real-world analytics and evidence needed for value-based healthcare. With its patented rapid-cycle analytics™ technology, the platform utilizes the everyday clinical and financial interactions of the healthcare system to unlock essential evidence about the effectiveness and value of medical treatments. Founded by Harvard Medical School faculty members and top big data technologists, Aetion enables payers and providers to collaborate with biopharmaceutical and medical device companies in real-time to develop therapeutic insights and make smart choices in patient care.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/20/17 | $11,200,000 | Series A |
Flare Capital Partners Lakestar | undisclosed |
| 04/11/18 | $36,000,000 | Series B |
Amgen Business Development Flare Capital Partners Lakestar Oxeon Partners | undisclosed |
| 02/05/19 | $27,000,000 | Series B |
Amgen Business Development Flare Capital Partners Horizon Healthcare Services Lakestar McKesson Ventures New Enterprise Associates Sanofi UCB | undisclosed |
| 08/27/20 | $82,000,000 | Series B |
Amgen Business Development Blue Cross Blue Shield of New Jersey EDBI Flare Capital Partners Johnson & Johnson Development Corporation (JJDC) Lakestar McKesson Ventures New Enterprise Associates Sanofi UCB | undisclosed |
| 05/11/21 | $110,000,000 | Series C |
B Capital Group Flare Capital Partners Foresite Capital New Enterprise Associates Warburg Pincus | undisclosed |
